Guardion Health Sciences Stock EBITDA
Guardion Health Sciences fundamentals help investors to digest information that contributes to Guardion Health's financial success or failures. It also enables traders to predict the movement of Guardion Pink Sheet. The fundamental analysis module provides a way to measure Guardion Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardion Health pink sheet.
Guardion |
Guardion Health Sciences Company EBITDA Analysis
Guardion Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Guardion Health EBITDA | (3.92 M) |
Most of Guardion Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardion Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Guardion Health Sciences reported earnings before interest,tax, depreciation and amortization of (3.92 Million). This is 100.45% lower than that of the Personal Care Products sector and significantly lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 100.1% higher than that of the company.
Guardion EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardion Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guardion Health could also be used in its relative valuation, which is a method of valuing Guardion Health by comparing valuation metrics of similar companies.Guardion Health is currently under evaluation in ebitda category among its peers.
Guardion Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | 0.52 % | |||
| Operating Margin | (18.75) % | |||
| Current Valuation | (987.33 K) | |||
| Shares Outstanding | 1.35 M | |||
| Shares Owned By Insiders | 1.30 % | |||
| Shares Owned By Institutions | 21.09 % | |||
| Number Of Shares Shorted | 22.26 K | |||
| Price To Earning | (0.71) X | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 12.25 M | |||
| Gross Profit | 4.52 M | |||
| EBITDA | (3.92 M) | |||
| Net Income | 158.03 K | |||
| Cash And Equivalents | 14.23 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 3.77 M | |||
| Current Ratio | 11.28 X | |||
| Book Value Per Share | 10.71 X | |||
| Cash Flow From Operations | (4.37 M) | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | (4.11) X | |||
| Target Price | 40.0 | |||
| Beta | 0.71 | |||
| Market Capitalization | 4.39 M | |||
| Total Asset | 11.92 M | |||
| Retained Earnings | (93.57 M) | |||
| Working Capital | 10.57 M | |||
| Current Asset | 12.8 M | |||
| Current Liabilities | 466.01 K | |||
| Annual Yield | 1.75 % | |||
| Net Asset | 11.92 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |